← All trials
NCT05334485
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2022
- Primary completion
- Jun 30, 2023
- Completion date
- Jul 31, 2023
- First posted
- Apr 19, 2022
- Last posted
- May 11, 2022
- Enrollment
- 50
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The Cleveland ClinicLead sponsor
- The Cleveland ClinicOverall official - principal investigator
- The Cleveland ClinicSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.